SPOTS ARE LIMITED! Register Now for the Care Oncology Webinar – Q&A with our UK and US Teams
Register for the Care Oncology webinar. March 26th, 7:00am Pacific – There is no cost to register
If you or someone you know has cancer, this webinar is for you. Ask questions directly of our UK and US medical teams. This webinar is open to anyone who has interest in learning more about the safety and efficacy of the COC Protocol.
Dr. Robin Bannister
Dr Robin Bannister is the inventor of the Care Oncology protocol for treating cancer and a co-founder of the Care Oncology clinic. Robin is a chemist by background training and studied at Imperial College, London receiving his PhD in 1988. His work focuses on the discovery of novel biology based on existing drugs and drug templates and the subsequent identification and exploitation of high–value, low-risk products.
Following his wife’s diagnosis with aggressive breast cancer, Robin spent years of evenings and weekends trawling the scientific literature for new treatment options. Due to a severe adverse reaction, she was unable to tolerate standard of care and had a poor prognosis, which inspired Robin to devise a combination of off-label medicines that worked together to suppress cancer’s metabolism. With this treatment, Robin’s wife had four years longer than expected with an excellent quality of life, before she passed in 2017.
In 2013, Robin joined forces with leading oncologists and co-founded a clinic in London offering this combination of off-label medicines as an adjunctive treatment to standard of care. This clinical service, known as the “Care Oncology Clinic” has now expanded to the United States, and globally more than 2,000 patients have been treated.
In order to change medical practice, the founding team understood that high-quality real-world evidence was needed to demonstrate that the protocol was both safe and effective. Robin and his team worked with the UK regulators (MHRA) to devise a new type of study framework that was specifically designed to gather evidence of real-world safety and efficacy. This study is known as an “Interventional Service Evaluation” and Care Oncology’s study has full MHRA and Ethics approval – a first in the field of oncology.
Care Oncology continues to expand in the USA and Robin continues to research cancer metabolism, aiming to reformulate some of the metabolic medicines used at the clinic, to improve their efficacy in cancer.
Dr. Daniel Thomas, DO, MS
Dr. Thomas earned his medical degree from Des Moines University and served his hospital intern-ship at Northwest General Hospital in Milwaukee, Wisconsin. Because medical education only begins in medical school, he didn’t stop there. In addition to a medical degree, Dr. Thomas earned a post-doctoral Master of Science degree in Metabolic and Nutritional Medicine from the University of South Florida College of Medicine. This advanced degree provided a deeper understanding of cellular biochemistry and human physiology than was taught in medical school.
The Master’s degree gave Dr. Thomas a greater understanding of the intimate connections between aging and disease, and metabolic dysfunction and faulty nutrition. It allowed him to provide even better care to his patients by giving him the knowledge on how to use the science of metabolic and nutritional medicine to prevent and reverse age-related diseases (including cancer), and stimulate metabolism, immunity, and cellular rejuvenation. Out of the 900,000 physicians in the United States, less than 0.01% have this important and cutting-edge degree.
In addition to a Master’s degree, Dr. Thomas has a post-doctoral Graduate Certificate in Metabolic Endocrinology and another in Clinical Neuroscience—both from the University of South Florida College of Medicine. This was followed by a Fellowship in Integrative Cancer Therapy with the Metabolic Medical Institute. Dr. Thomas also has a Bachelor of Science degree in Biochemistry from Andrews University as well as a Certificate in Plant-Based Nutrition from Cornell University. He is currently serving a two-year Fellowship in Advanced Metabolic Cardiology.
Dr Padman Vamadevan
Dr Padman Vamadevan undertook a Natural Sciences degree at Queens’ College, Cambridge, and subsequently completed his medical degree on the fast-track programme at Guy’s, King’s and St Thomas’ School of Medicine in London. He subsequently secured an Academic Foundation training post at Guy’s & St Thomas’ Hospitals, during which he was seconded to Quintiles Drug Research Unit where he was involved in trial design and management and data analysis.
Following this, he was appointed as an Academic Clinical Fellow in Clinical Pharmacology at St George’s Hospital and during this period, published multiple peer-reviewed papers, whilst also receiving a travel fellowship to speak at the European Respiratory Society congress. Subsequently, he has taken up a variety of Haematological and Oncological posts at a variety of leading cancer institutions in London, which have afforded him significant relevant clinical experiance.
He has worked at the Care Oncology Clinic for over two years, and his familiarity with Biochemistry, Clinical Pharmacology, Clinical Research Studies and Oncology are consistent with the academic lineages that underpin the metabolic treatments offered by the clinic.
Other team members from the UK and US will also be joining the webinar. We’ll update this page as this information is available.